4//SEC Filing
RXi Pharmaceuticals Corp 4
Accession 0001181431-13-047016
$PHIOCIK 0001533040operating
Filed
Aug 29, 8:00 PM ET
Accepted
Aug 30, 10:28 AM ET
Size
4.3 KB
Accession
0001181431-13-047016
Insider Transaction Report
Form 4
Lockshin Curtis
Director
Transactions
- Purchase
Common stock, $0.0001 par value
2013-08-29$3.70/sh+1,000$3,700→ 1,000 total
Documents
Issuer
RXi Pharmaceuticals Corp
CIK 0001533040
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001533040
Filing Metadata
- Form type
- 4
- Filed
- Aug 29, 8:00 PM ET
- Accepted
- Aug 30, 10:28 AM ET
- Size
- 4.3 KB